Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (3389)	11/8/2013 11:41:18 AM
From: Savant	Respond to of 3576

It's not so hard for me to believe. It is one of the reasons I bought the stock, but, in addition, at one time, I felt I was helping advance science, in my own small way. Rather like Reeves, when he invested a much larger sum. But, net-net, most of the big money, wants a return on their money....and earnings are one of many metrics. Additionally, it speaks to how the company is managing their/our money, and gives an indication as to how long they might be able to stay in the business of scientific research. Best, Savant PS, I'm long the stock.

To: seminole who wrote (3389)	11/8/2013 11:52:05 AM
From: deeno	Respond to of 3576

"It is hard for me to believe that anyone would own or sell Geron based upon current revenue numbers." they wouldnt. but really do you own ANY stock for what they currently do? it's the potential. I'm just along for the ride. rooting more for the "cure" than the money, but in the end they are hardly seperable. Most of the analysts want to "see more" before they change their competive landscape. Once that s done in the next few weeks there wont be any time to either get in or get out. Just a roll of the dice I'm afraid. So far, that last roll was an 8.